One Stop Solution For In-Depth Market Research Reports

詳細な市場調査レポートのワンストップソリューション

Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Toxicology Services Global Market

毒物学サービスグローバル市場ー業界洞察、主要プレーヤー・企業別、成長機会別、最新傾向別、開発別、主要な成長ドライバー別、主要な課題別によってセグメンテーション、予測 2028年


[ 英語タイトル ] Toxicology Services Global Market - Forecast To 2028


Product Code : IQ4IHC00116245
Survey : IQ4I
Publish On : December, 2021
Category : Healthcare and Pharmaceuticals
Study Area : North America (U.S. and Others), Europe (Germany, France, U.K. and Others), Asia-Pacific (Japan, China, India, and Others), Rest of World (Brazil, Rest of Latin America, and Middle East & Others)
Report format : PDF
Sales price option (consumption tax not included)
Single User USD4950 / Question Form
5 User USD6750 / Question Form
Enterprise User USD9000 / Question Form
CHARLES RIVER LABORATORIES
CMIC HOLDINGS CO., LTD
EVOTEC SE
EUROFINS SCIENTIFIC S.E.
INOTIV INC.
ITR LABORATORIES CANADA INC.
LABCORP CORPORATION OF AMERICA HOLDINGS
NORTH AMERICAN SCIENCE ASSOCIATES, LLC
PHARMARON BEIJING CO., LIMITED
SGS SA
WUXI APPTEC
LIST OF COMPANIES MENTIONED IN THE REPORT

[Report Description]

Toxicology is the study of adverse effects that occur in living organisms and its environment due to chemicals, physical or biological substances at ambient exposure levels. Toxicology testing regulations are already in place for most of the developed countries across industries such as chemicals, pesticides, consumer goods, medical products, and food additives. These toxicology tests are important for the approval of products and with the increased trend for outsourcing, toxicology studies are also being outsourced across the industries.
According to IQ4I analysis, the toxicology services global market is expected to grow at a mid single digit CAGR from 2021 to 2028 to reach $17,043.0 million by 2028. The factors such as mandatory toxicology testing requirement for various industries like pharma, medical device, cosmetic, chemical and food for their product approvals or registration, increased trend of outsourcing, increase in pharma R&D expenditure are driving the toxicology services market. Whereas, the emergence of advanced technology likes 3D-model, ex-vivo, organ-on-a chip and in-silico tool, increasing in utilization of nano-materials and regulatory changes to enhance safety profiles of agents will provide immense growth opportunities for toxicology services market in future. However, increasing focus towards drug repurposing, lack of skilled personnel, high cost and long duration of the tests and stringent government regulations towards the animal studies are expected to hamper the market growth.
The market for toxicology services is segmented based on study methods, industry, end-points and geography. Based on the study methodologies, the market is segmented into In Vivo, In Vitro and In-Silico. Among the study methodologies, in-vitro toxicity services accounted for the highest revenue in 2021 and are expected grow at a mid single digit CAGR from 2021 to 2028. The In-vitro toxicology services market is further segmented in to Cellular & Biochemical assays, Ex Vivo and 3D-model and Organ-on-a-chips. Among these, Cellular & Biochemical assay segment is accounted for the largest revenue in 2021 and is expected to grow at a mid single digit CAGR from 2021 to 2028. 3D-model and Organ-on-a-chips is expected to grow at a high single digit CAGR from 2021 to 2028 to due to increasing adoption of 3D model and organ on a chip based assays in toxicology studies.
Based on the industry, toxicology services market is classified into Pharmaceutical, medical device, chemical, cosmetics and others. Among the industries, Pharmaceutical segment is accounted for the highest revenue in 2021 and is expected to grow at a mid single digit CAGR from 2021 to 2028. Medical devices are expected to grow at a high single digit CAGR from 2021 to 2028. Pharmaceutical segment is further sub-segmented into drug discovery and developmental toxicology. Among these, drug developmental toxicology is accounted for the highest revenue in 2021 and is expected to grow at a mid single digit CAGR from 2021 to 2028. Drug discovery toxicology is expected to grow at mid single digit CAGR from 2021 to 2028. The chemical segment is further segmented into industrial chemical and agrochemicals. Among these, industrial chemical is accounted for the highest revenue of in 2021 and is expected to grow at a mid single digit CAGR from 2021 to 2028. AgroChemical segment is expected to grow at a high single digit CAGR from 2021 to 2028. Other industries segment is further segmented into food, consumer goods, environment and others. Among these, environment segment is accounted for the highest revenue in 2021 and is expected to grow at a mid single digit CAGR from 2021 to 2028.
According to IQ4I analysis, the end-points market are categorized into acute toxicity, chronic toxicity, dermal toxicology, ocular toxicology, safety pharmacology, reproductive and developmental toxicology, genotoxicity, carcinogenicity, neurotoxicity, ecotoxicolgoy and others. Among these, acute toxicology segment is accounted for the highest revenue of in 2021 and is expected to grow at a mid single digit CAGR from 2021 to 2028. Developmental & Reproductive toxicology is expected to grow at high single digit CAGR from 2021 to 2028
By geography, the toxicology services global market is segmented into North America (U.S. and Rest of North America), Europe (Germany, France, U.K. and Rest of Europe), Asia-Pacific (Japan, China, India, and Rest of APAC) and the Rest of the world (Brazil, Rest of Latin America and the Middle East & Africa). North America accounted for the largest revenue in 2021 and is expected to grow at a mid single digit CAGR from 2021 to 2028. The factors such as increasing R&D expenditure, mandatory toxicology studies required for new drug, chemical, food additive, agrochemical and chemical to enter into the market, increase in development of new drugs, increase in development of novel medical devices and increasing adoption of advanced technologies and novel in-vitro and in-silico models to expand the services capabilities by the toxicity service providers are driving the toxicology services market in the region.
Asia-Pacific is expected to grow at a high single digit CAGR from 2021 to 2028 due to growing pharma and biopharma industries with development of innovative drugs into the market, mandatory regulatory toxicology studies needed for approval of new drugs, medical device, agrochemical into the market, increasing number of agrichemical registrations, increasing government investment towards the pharma and biopharam industries. Further, changing regulations to ensure further safety profiles of pesticides will boost the demand for toxicology services in the region future.
The toxicology services global market is competitive and all the players in this market are involved in adopting advanced technologies in toxicology studies to expand their service offerings and maintain their market shares.
The key players in the Toxicology services global market include Charles River Laboratories International (U.S.), CMIC Holdings Co., Ltd (Japan), Evotec SE (Germany), Eurofins Scientific S.E. (Luxemburg), Inotiv, Inc. (U.S.), North American Science Associates, LLC (U.S.), Laboratory Corporation of America Holdings (U.S.), ITR Laboratories Canada Inc. (Canada), Pharmaron Beijing Co. Ltd. (China), SGS SA (Switzerland) and Wuxi Apptec (China).
The report provides an in-depth market analysis of the above-mentioned segments across the following regions:
• North America
o U.S.
o Rest of North America
• Europe
o Germany
o U.K.
o France
o Rest of Europe
• Asia-Pacific
o China
o Japan
o India
o Rest of APAC
• Rest of the World (RoW)
o Brazil
o Rest of Latin America
o Middle East and Others


1 EXECUTIVE SUMMARY 24
2 INTRODUCTION 33
2.1 KEY TAKEAWAYS 33
2.2 SCOPE OF THE REPORT 34
2.3 REPORT DESCRIPTION 34
2.4 MARKETS COVERED 37
2.5 STAKEHOLDERS 39
2.6 RESEARCH METHODOLOGY 39
2.6.1 MARKET SIZE ESTIMATION 42
2.6.2 MARKET BREAKDOWN AND DATA TRIANGULATION 44
2.6.3 SECONDARY SOURCES 45
2.6.4 KEY DATA POINTS FROM SECONDARY SOURCES 45
2.6.5 PRIMARY SOURCES 46
2.6.6 KEY DATA POINTS FROM PRIMARY SOURCES 46
2.6.7 ASSUMPTIONS 47
3 MARKET ANALYSIS 48
3.1 INTRODUCTION 48
3.2 MARKET SEGMENTATION 49
3.3 FACTORS INFLUENCING MARKET 51
3.3.1 DRIVERS AND OPPORTUNITIES 52
3.3.1.1 Increasing outsourcing trend 52
3.3.1.2 Increase in pharma R&D spending 54
3.3.1.3 Emergence in advance technologies 55
3.3.1.4 Increase in utilization of nano-materials 58
3.3.1.5 Lack of availability of toxicity data of agents and regulatory changes or action to enhance the safety use of agents (e.g., chemicals, food additives, drugs) 60
3.3.2 RESTRAINTS AND THREATS 61
3.3.2.1 Increase in drug repurposing 61
3.3.2.2 High cost and long duration of tests 62
3.3.2.3 Ethical Issues associated with toxicity testing 63
3.3.2.4 Compliance with stringent regulatory guidelines 64
3.4 REGULATORY AFFAIRS 65
3.4.1 INTRODUCTION 65
3.4.2 PHARMACEUTICALS 65
3.4.3 MEDICAL DEVICES 67
3.4.4 COSMETICS 68
3.4.5 INDUSTRIAL CHEMICAL AND AGRICULTURAL CHEMICAL AND FOOD 69
3.4.5.1 Chemical 69
3.4.5.2 Agro-Chemical 71
3.4.5.3 Food 73
3.5 MATRIX OF GLP CERTIFIED TEST FACILITIES IN INDIA 74
3.6 MARKET SHARE ANALYSIS BY MAJOR PLAYERS 92
3.6.1 TOXICOLOGY SERVICES GLOBAL MARKET SHARE ANALYSIS 92
4 TOXICOLOGY SERVICES GLOBAL MARKET, BY STUDY METHODS 97
4.1 INTRODUCTION 97
4.2 IN VIVO TOXICOLOGY 100
4.3 IN VITRO TOXICOLOGY 104
4.3.1 CELLULAR AND BIOCHEMICAL ASSAYS 110
4.3.2 EX VIVO 113
4.3.3 3D-MODEL AND ORGAN-ON-A-CHIP 116
4.4 IN SILICO TOXICOLOGY 120
5 TOXICOLOGY SERVICES GLOBAL MARKET, BY INDUSTRY 125
5.1 INTRODUCTION 125
5.2 PHARMACEUTICAL 128
5.2.1 DRUG DISCOVERY TOXICOLOGY 139
5.2.2 DRUG DEVELOPMENTAL TOXICOLOGY 141
5.3 MEDICAL DEVICES 143
5.4 COSMETICS 150
5.5 CHEMICAL 155
5.5.1 INDUSTRIAL CHEMICAL 159
5.5.2 AGROCHEMICAL 161
5.6 OTHERS 167
5.6.1 FOOD 170
5.6.2 CONSUMER GOODS 173
5.6.3 ENVIRONMENT 175
5.6.4 OTHERS 177
6 TOXICOLOGY SERVICES GLOBAL MARKET, BY ENDPOINTS 179
6.1 INTRODUCTION 179
6.2 ACUTE TOXICOLOGY 182
6.3 CHRONIC TOXICOLOGY 185
6.4 DERMAL TOXICOLOGY 188
6.5 NEUROTOXICOLOGY 192
6.6 OCULAR TOXICOLOGY 195
6.7 GENOTOXICOLOGY 198
6.8 DEVELOPMENTAL & REPRODUCTIVE TOXICOLOGY 202
6.9 CARCINOGENICITY 206
6.10 SAFETY PHARMACOLOGY 209
6.11 ECOTOXICOLOGY 213
6.12 OTHERS 217
7 REGIONAL ANALYSIS 220
7.1 INTRODUCTION 220
7.2 NORTH AMERICA 225
7.2.1 U.S. 243
7.2.2 REST OF NORTH AMERICA 247
7.3 EUROPE 251
7.3.1 GERMANY 270
7.3.2 FRANCE 274
7.3.3 U.K. 277
7.3.4 REST OF EUROPE 280
7.4 ASIA-PACIFIC 283
7.4.1 JAPAN 300
7.4.2 CHINA 304
7.4.3 INDIA 307
7.4.4 REST OF APAC 312
7.5 ROW 315
7.5.1 BRAZIL 331
7.5.2 REST OF LATIN AMERICA 334
7.5.3 MIDDLE EAST & OTHERS 337
8 MAJOR COMPANIES 342
8.1 CHARLES RIVER LABORATORIES INTERNATIONAL, INC. 342
8.1.1 OVERVIEW 342
8.1.2 FINANCIALS 343
8.1.3 SERVICE PORTFOLIO 345
8.1.4 KEY DEVELOPMENTS 346
8.1.5 BUSINESS STRATEGY 347
8.1.6 SWOT ANALYSIS 348
8.2 CMIC HOLDINGS CO., LTD. 349
8.2.1 OVERVIEW 349
8.2.2 FINANCIALS 350
8.2.3 SERVICES PORTFOLIO 351
8.2.4 KEY DEVELOPMENTS 352
8.2.5 BUSINESS STRATEGY 352
8.2.6 SWOT ANALYSIS 353
8.3 EVOTEC SE 354
8.3.1 OVERVIEW 354
8.3.2 FINANCIALS 355
8.3.3 SERVICE PORTFOLIO 357
8.3.4 KEY DEVELOPMENSTS 359
8.3.5 BUSINESS STRATEGY 360
8.3.6 SWOT ANALYSIS 361
8.4 EUROFINS SCIENTIFIC S.E 362
8.4.1 OVERVIEW 362
8.4.2 FINANCIALS 363
8.4.3 SERVICE PORTFOLIO 364
8.4.4 KEY DEVELOPMENTS 368
8.4.5 BUSINESS STRATEGY 368
8.4.6 SWOT ANALYSIS 369
8.5 INOTIV, INC. 370
8.5.1 OVERVIEW 370
8.5.2 FINANCIALS 371
8.5.3 SERVICE PORTFOLIO 372
8.5.4 KEY DEVELOPMENTS 372
8.5.5 BUSINESS STRATEGY 373
8.5.6 SWOT ANALYSIS 374
8.6 ITR LABORATORIES CANADA INC. 375
8.6.1 OVERVIEW 375
8.6.2 FINANCIALS 375
8.6.3 SERVICE PORTFOLIO 376
8.6.4 KEY DEVELOPMENTS 376
8.6.5 BUSINESS STRATEGY 376
8.6.6 SWOT ANALYSIS 377
8.7 LABORATORY CORPORATION OF AMERICA HOLDINGS 378
8.7.1 OVERVIEW 378
8.7.2 FINANCIALS 379
8.7.3 SERVICE PORTFOLIO 380
8.7.4 KEY DEVELOPMENTS 384
8.7.5 BUSINESS STRATEGY 384
8.7.6 SWOT ANALYSIS 385
8.8 NORTH AMERICAN SCIENCE ASSOCIATES, LLC 386
8.8.1 OVERVIEW 386
8.8.2 FINANCIALS 386
8.8.3 SERVICE PORTFOLIO 386
8.8.4 KEY DEVELOPMENTS 388
8.8.5 BUSINESS STRATEGY 388
8.8.6 SWOT ANALYSIS 389
8.9 PHARMARON BEIJING CO., LTD. 390
8.9.1 OVERVIEW 390
8.9.2 FINANCIALS 391
8.9.3 SERVICE PORTFOLIO 393
8.9.4 KEY DEVELOPMENTS 394
8.9.5 BUSINESS STRATEGY 395
8.9.6 SWOT ANALYSIS 396
8.10 SGS SA 397
8.10.1 OVERVIEW 397
8.10.2 FINANCIALS 398
8.10.3 SERVICE PORTFOLIO 399
8.10.4 KEY DEVELOPMENTS 400
8.10.5 BUSINESS STRATEGY 400
8.10.6 SWOT ANALYSIS 401
8.11 WUXI APPTEC 402
8.11.1 OVERVIEW 402
8.11.2 FINANCIALS 403
8.11.3 SERVICE PORTFOLIO 405
8.11.4 KEY DEVELOPMENTS 408
8.11.5 BUSINESS STRATEGY 409
8.11.6 SWOT ANALYSIS 410

LIST OF TABLES
TABLE 1 TOXICOLOGY SERVICES GLOBAL MARKET REVENUE, BY REGION,
(2020-2028) ($MN) 31
TABLE 2 TOXICOLOGY SERVICES MATRIX, BASED ON INDUSTRY 86
TABLE 3 TOXICOLOGY SERVICES MATRIX, BASED ON END-POINTS 89
TABLE 4 TOXICOLOGY SERVICES GLOBAL MARKET REVENUE, BY METHODS,
(2020-2028) ($MN) 98
TABLE 5 IN VIVO TOXICOLOGY SERVICES GLOBAL MARKET REVENUE, BY REGION, (2020-2028) ($MN) 103
TABLE 6 IN VITRO TOXICOLOGY SERVICES GLOBAL MARKET REVENUE, BY TYPE, (2020-2028) ($MN) 106
TABLE 7 IN VITRO TOXICOLOGY SERVICES GLOBAL MARKET REVENUE, BY REGION, (2020 -2028) ($MN) 108
TABLE 8 CELLULAR AND BIOCHEMICAL ASSAYS GLOBAL MARKET REVENUE, BY REGION, (2020-2028) ($MN) 112
TABLE 9 EX VIVO GLOBAL MARKET REVENUE, BY REGION, (2020-2028) ($MN) 115
TABLE 10 3D-MODEL AND ORGAN-ON-A-CHIP GLOBAL MARKET REVENUE, BY REGION, (2020-2028) ($MN) 119
TABLE 11 IN SILICO TOXICOLOGY GLOBAL MARKET REVENUE, BY REGION,
(2020-2028) ($MN) 124
TABLE 12 TOXICOLOGY SERVICES GLOBAL MARKET REVENUE, BY INDUSTRY,
(2020-2028) ($MN) 126
TABLE 13 PHARMACEUTICAL INDUSTRY GLOBAL MARKET REVENUE, BY TYPE,
(2020-2028) ($MN) 136
TABLE 14 PHARMACEUTICAL INDUSTRY GLOBAL MARKET REVENUE, BY REGION, (2020-2028) ($MN) 138
TABLE 15 DRUG DISCOVERY TOXICOLOGY GLOBAL MARKET REVENUE, BY REGION, (2020-2028) ($MN) 140
TABLE 16 DRUG DEVELOPMENTAL TOXICOLOGY GLOBAL MARKET REVENUE, BY REGION, (2020-2028) ($MN) 142
TABLE 17 MEDICAL DEVICE INDUSTRY GLOBAL MARKET REVENUE, BY REGION,
(2020-2028) ($MN) 150
TABLE 18 COSMETIC GROUPS/CLASSES 151
TABLE 19 COSMETIC INDUSTRY GLOBAL MARKET REVENUE, BY REGION,
(2020-2028) ($MN) 154
TABLE 20 CHEMICAL INDUSTRY GLOBAL MARKET REVENUE, BY TYPE,
(2020-2028) ($MN) 156
TABLE 21 CHEMICAL INDUSTRY GLOBAL MARKET REVENUE, BY REGION,
(2020-2028) ($MN) 158
TABLE 22 INDUSTRIAL CHEMICAL GLOBAL MARKET REVENUE, BY REGION,
(2020-2028) ($MN) 160
TABLE 23 TESTS REQUIRED BY THE EPA FOR NEW PESTICIDE CHEMICAL 162
TABLE 24 ESTIMATED COST OF TOXICITY STUDIES FOR PESTICIDE REGISTRATION 164
TABLE 25 AGROCHEMICAL GLOBAL MARKET REVENUE, BY REGION, (2020-2028) ($MN) 166
TABLE 26 OTHER INDUSTRY GLOBAL MARKET REVENUE, BY TYPE, (2020-2028) ($MN) 167
TABLE 27 OTHER INDUSTRY GLOBAL MARKET REVENUE, BY REGION,
(2020-2028) ($MN) 169
TABLE 28 FOOD INDUSTRY GLOBAL MARKET REVENUE, BY REGION,
(2020-2028) ($MN) 172
TABLE 29 CONSUMER GOODS GLOBAL MARKET REVENUE, BY REGION,
(2020-2028) ($MN) 174
TABLE 30 ENVIORNMENTAL INDUSTRY GLOBAL MARKET REVENUE, BY REGION,
(2020-2028) ($MN) 176
TABLE 31 OTHERS GLOBAL MARKET REVENUE, BY REGION, (2020-2028) ($MN) 178
TABLE 32 TOXICOLOGY SERVICES GLOBAL MARKET REVENUE, BY ENDPOINTS,
(2020-2028) ($MN) 180
TABLE 33 ACUTE TOXICOLOGY GLOBAL MARKET REVENUE, BY REGION,
(2020-2028) ($MN) 184
TABLE 34 CHRONIC TOXICOLOGY GLOBAL MARKET REVENUE, BY REGION,
(2020-2028) ($MN) 187
TABLE 35 DERMAL TOXICOLOGY GLOBAL MARKET REVENUE, BY REGION,
(2020-2028) ($MN) 192
TABLE 36 NEUROTOXICOLOGY GLOBAL MARKET REVENUE, BY REGION,
(2020-2028) ($MN) 194
TABLE 37 OCULAR TOXICOLOGY GLOBAL MARKET REVENUE, BY REGION,
(2020-2028) ($MN) 198
TABLE 38 GENOTOXICOLOGY GLOBAL MARKET REVENUE, BY REGION,
(2020-2028) ($MN) 202
TABLE 39 DEVELOPMENTAL & REPRODUCTIVE TOXICOLOGY GLOBAL MARKET REVENUE, BY REGION, (2020-2028) ($MN) 206
TABLE 40 CARCINOGENICITY GLOBAL MARKET REVENUE, BY REGION,
(2020-2028) ($MN) 209
TABLE 41 SAFETY PHARMACOLOGY GLOBAL MARKET REVENUE, BY REGION,
(2020-2028) ($MN) 212
TABLE 42 ECOTOXICOLOGY GLOBAL MARKET REVENUE, BY REGION,
(2020-2028) ($MN) 216
TABLE 43 OTHER TOXICOLOGY GLOBAL MARKET REVENUE, BY REGION,
(2020-2028) ($MN) 219
TABLE 44 TOXICOLOGY SERVICES GLOBAL MARKET REVENUE, BY REGION,
(2020-2028) ($MN) 222
TABLE 45 NORTH AMERICA TOXICOLOGY SERVICES MARKET REVENUE, BY METHODS, (2020-2028) ($MN) 228
TABLE 46 NORTH AMERICA IN VITRO TOXICOLOGY SERVICES MARKET REVENUE, BY TYPE, (2020-2028) ($MN) 229
TABLE 47 NORTH AMERICA TOXICOLOGY SERVICE MARKET REVENUE, BY INDUSTRY, (2020-2028) ($MN) 230
TABLE 48 NORTH AMERICA PHARMACEUTICAL INDUSTRY MARKET REVENUE, BY TYPE, (2020-2028) ($MN) 231
TABLE 49 NORTH AMERICA CHEMICAL INDUSTRY MARKET REVENUE, BY TYPE,
(2020-2028) ($MN) 232
TABLE 50 NORTH AMERICA OTHER INDUSTRY MARKET REVENUE, BY TYPE,
(2020-2028) ($MN) 233
TABLE 51 NORTH AMERICA TOXICOLOGY SERVICE MARKET REVENUE, BY ENDPOINTS, (2020-2028) ($MN) 234
TABLE 52 NORTH AMERICA TOXICOLOGY SERVICES MARKET REVENUE, BY COUNTRY (2020-2028) ($MN) 242
TABLE 53 EUROPE TOXICOLOGY SERVICES MARKET REVENUE, BY METHODS,
(2020-2028) ($MN) 255
TABLE 54 EUROPE IN VITRO TOXICOLOGY SERVICES MARKET REVENUE, BY TYPE, (2020-2028) ($MN) 256
TABLE 55 EUROPE TOXICOLOGY SERVICE MARKET REVENUE, BY INDUSTRY,
(2020-2028) ($MN) 257
TABLE 56 EUROPE PHARMACEUTICAL INDUSTRY MARKET REVENUE, BY TYPE,
(2020-2028) ($MN) 258
TABLE 57 EUROPE CHEMICAL INDUSTRY MARKET REVENUE, BY TYPE,
(2020-2028) ($MN) 259
TABLE 58 EUROPE OTHER INDUSTRY MARKET REVENUE, BY TYPE, (2020-2028) ($MN) 260
TABLE 59 EUROPE TOXICOLOGY SERVICE MARKET REVENUE, BY ENDPOINTS,
(2020-2028) ($MN) 261
TABLE 60 EUROPE TOXICOLOGY SERVICES MARKET REVENUE, BY COUNTRY,
(2020-2028) ($MN) 269
TABLE 61 APAC TOXICOLOGY SERVICES MARKET REVENUE, BY METHODS,
(2020-2028) ($MN) 286
TABLE 62 APAC IN VITRO TOXICOLOGY SERVICES MARKET REVENUE, BY TYPE,
(2020-2028) ($MN) 287
TABLE 63 APAC TOXICOLOGY SERVICE MARKET REVENUE, BY INDUSTRY,
(2020-2028) ($MN) 288
TABLE 64 APAC PHARMACEUTICAL INDUSTRY MARKET REVENUE, BY TYPE,
(2020-2028) ($MN) 289
TABLE 65 APAC CHEMICAL INDUSTRY MARKET REVENUE, BY TYPE, (2020-2028) ($MN) 289
TABLE 66 APAC OTHER INDUSTRY MARKET REVENUE, BY TYPE, (2020-2028) ($MN) 290
TABLE 67 APAC TOXICOLOGY SERVICE MARKET REVENUE, BY ENDPOINTS,
(2020-2028) ($MN) 291
TABLE 68 ASIA-PACIFIC TOXICOLOGY SERVICES MARKET REVENUE, BY COUNTRY, (2020-2028) ($MN) 299
TABLE 69 ROW TOXICOLOGY SERVICES MARKET REVENUE, BY METHODS,
(2020-2028) ($MN) 317
TABLE 70 ROW IN VITRO TOXICOLOGY SERVICES MARKET REVENUE, BY TYPE,
(2020-2028) ($MN) 318
TABLE 71 ROW TOXICOLOGY SERVICE MARKET REVENUE, BY INDUSTRY,
(2020-2028) ($MN) 319
TABLE 72 ROW PHARMACEUTICAL INDUSTRY MARKET REVENUE, BY TYPE,
(2020-2028) ($MN) 320
TABLE 73 ROW CHEMICAL INDUSTRY MARKET REVENUE, BY TYPE, (2020-2028) ($MN) 321
TABLE 74 ROW OTHER INDUSTRY MARKET REVENUE, BY TYPE, (2020-2028) ($MN) 321
TABLE 75 ROW TOXICOLOGY SERVICE MARKET REVENUE, BY ENDPOINTS,
(2020-2028) ($MN) 322
TABLE 76 ROW TOXICOLOGY SERVICESMARKET REVENUE, BY COUNTRY,
(2020-2028) ($MN) 330
TABLE 77 CHARLES RIVER LABORATORIES : TOTAL REVENUE AND R&D EXPENSES, (2019-2021) (Q2) ($MN) 343
TABLE 78 CHARLES RIVER LABORATORIES : TOTAL REVENUE, BY SEGMENTS,
(2019-2021) (Q2) ($MN) 343
TABLE 79 CHARLES RIVER LABORATORIES : TOTAL REVENUE, BY GEOGRAPHY,
(2019-2021) (Q2) ($MN) 344
TABLE 80 CMIC HOLDINGS CO., LTD: TOTAL REVENUE AND R&D EXPENSES,
(2019-2021) (Q3) ($MN) 350
TABLE 81 CMIC HOLDINGS CO., LTD: TOTAL REVENUE, BY SEGMENTS,
(2019-2021) (Q3) ($MN) 351
TABLE 82 EVOTEC SE: TOTAL REVENUE AND R&D EXPENSES, (2019-2021)(Q2) ($MN) 355
TABLE 83 EVOTEC SE: TOTAL REVENUE, BY SEGMENTS, (2019-2021) (Q2) ($MN) 356
TABLE 84 EVOTEC SE: TOTAL REVENUE, BY GEOGRAPHY, (2019-2021) (Q2) ($MN) 357
TABLE 85 EUROFINS SCIENTIFIC S.E.: TOTAL REVENUE AND R&D EXPENSES,
(2019-2021) (Q3) ($MN) 363
TABLE 86 EUROFINS SCIENTIFIC S.E.: TOTAL REVENUE, BY SEGMENTS,
(2019-2021) (Q3) ($MN) 363
TABLE 87 INOTIV, INC.: TOTAL REVENUE AND R&D EXPENSES
(2019-2021) (Q3) ($MN) 371
TABLE 88 INOTIV, INC.: TOTAL REVENUE, BY SEGMENT, (2019-2021)(Q3) ($MN) 371
TABLE 89 INOTIV, INC.: TOTAL REVENUE, BY REGION, (2019-2021) (Q3) ($MN) 372
TABLE 90 LABORATORY CORPORATION OF AMERICA HOLDINGS: TOTAL REVENUE AND R&D EXPENSES, (2019-2021) (Q3) ($MN) 379
TABLE 91 LABORATORY CORPORATION OF AMERICA HOLDINGS: TOTAL REVENUE, BY SEGMENT, (2019-2021) (Q3) ($MN) 379
TABLE 92 LABORATORY CORPORATION OF AMERICA HOLDINGS: TOTAL REVENUE, BY GEOGRAPHY, (2019-2021) (Q3)($MN) 380
TABLE 93 PHARMARON BEIJING CO., LTD.: TOTAL REVENUE AND R&D EXPENSES, (2019-2020) (Q2) ($MN) 391
TABLE 94 PHARMARON BEIJING CO., LTD.: TOTAL REVENUE, BY SEGMENTS,
(2019-2021) (Q2) ($MN) 392
TABLE 95 PHARMARON BEIJING CO., LTD.: TOTAL REVENUE, BY GEOGRAPHY,
(2019-2021) (Q2) ($MN) 393
TABLE 96 SGS SA : TOTAL REVENUE AND R&D EXPENSES, (2019-2021) (Q2) ($MN) 398
TABLE 97 SGS SA: TOTAL REVENUE BY SEGMENT, (2019-2021) (Q2) ($MN) 399
TABLE 98 WUXI APPTEC : TOTAL REVENUE AND R&D EXPENSES,
(2019-2021)(Q2) ($MN) 403
TABLE 99 WUXI APPTEC : TOTAL REVENUE, BY SEGMENTS, (2019-2021) (Q2) ($MN) 404
TABLE 100 WUXI APPTEC: TOTAL REVENUE, BY GEOGRAPHY, (2019-2021) (Q2) ($MN) 405

LIST OF FIGURES
FIGURE 1 TOXICOLOGY SERVICES GLOBAL MARKET REVENUE, BY REGION
(2020-2028) ($MN) 32
FIGURE 2 RESEARCH METHODOLOGY: TOXICOLOGY SERVICES GLOBAL MARKET 41
FIGURE 3 TOXICOLOGY SERVICES GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH 42
FIGURE 4 TOXICOLOGY SERVICES GLOBAL MARKET: FORECASTING MODEL 43
FIGURE 5 TOXICOLOGY SERVICES GLOBAL MARKET: MARKET BREAKDOWN AND DATA TRIANGULATION 44
FIGURE 6 TOXICOLOGY SERVICES GLOBAL MARKET SEGMENTATION 50
FIGURE 7 MARKET DYNAMICS 51
FIGURE 8 GLP CERTIFIED TEST FACILITIES OF INDIAN CRO’S BY INDUSTRY 74
FIGURE 9 TOXICOLOGY SERVICES GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2021 (%) 92
FIGURE 10 TOXICOLOGY SERVICES GLOBAL MARKET SHARE, BY METHODS
(2021 V/S 2028) (%) 99
FIGURE 11 IN VITRO TOXICOLOGY SERVICES GLOBAL MARKET SHARE, BY TYPE
(2021 V/S 2028) (%) 107
FIGURE 12 IN VITRO TOXICOLOGY SERVICES GLOBAL MARKET SHARE, BY REGION, (2021 V/S 2028) (%) 109
FIGURE 13 CELLULAR AND BIOCHEMICAL ASSAYS GLOBAL MARKET SHARE, BY REGION, (2021 V/S 2028) (%) 113
FIGURE 14 EX VIVO TOXICOLOGY GLOBAL MARKET SHARE, BY REGION,
(2021 V/S 2028) (%) 116
FIGURE 15 TOXICOLOGY SERVICESGLOBAL MARKET SHARE, BY INDUSTRY
(2021 V/S 2028) (%) 127
FIGURE 16 TOXICOLOGY STUDIES IN DRUG DISCOVERY AND DEVELOPMENT 129
FIGURE 17 TOXICOLOGY STUDIES IN DRUG DISCOVERY AND DEVELOPMENT 130
FIGURE 18 TOXICOLOGY STUDIES IN DRUG DISCOVERY AND DEVELOPMENT 131
FIGURE 19 PHARMACEUTICAL INDUSTRY GLOBAL MARKET SHARE, BY TYPE
(2021 V/S 2028) (%) 137
FIGURE 20 DRUG DISCOVERY TOXICOLOGY GLOBAL MARKET SHARE, BY REGION,
(2021 V/S 2028) (%) 141
FIGURE 21 COSMETIC INDUSTRY GLOBAL MARKET SHARE, BY REGION,
(2021 V/S 2028) (%) 155
FIGURE 22 CHEMICAL INDUSTRY GLOBAL MARKET SHARE, BY TYPE (2021 V/S 2028) (%) 157
FIGURE 23 OTHER INDUSTRY GLOBAL MARKET SHARE, BY TYPE (2021 V/S 2028) (%) 168
FIGURE 24 OTHER INDUSTRY GLOBAL MARKET SHARE, BY REGION, (2021 V/S 2028) (%) 170
FIGURE 25 OTHER INDUSTRY GLOBAL MARKET SHARE, BY REGION, (2021 V/S 2028) (%) 173
FIGURE 26 TOXICOLOGY SERVICES GLOBAL MARKET SHARE, BY ENDPOINTS
(2021 V/S 2028) (%) 181
FIGURE 27 TOXICOLOGY SERVICES GLOBAL MARKET REVENUE, BY REGION
(2020-2028) ($MN), CAGR (%) 223
FIGURE 28 TOXICOLOGY SERVICES GLOBAL MARKET REVENUE, BY GEOGRAPHY (2021) ($ MN) 224
FIGURE 29 NORTH AMERICA TOXICOLOGY SERVICES MARKET SHARE, BY METHODS (2021 V/S 2028) (%) 235
FIGURE 30 IN VITRO TOXICOLOGY SERVICES MARKET SHARE, BY TYPE
(2021 V/S 2028) (%) 236
FIGURE 31 NORTH AMERICA TOXICOLOGY SERVICES MARKET SHARE, BY INDUSTRY (2021 V/S 2028) (%) 237
FIGURE 32 NORTH AMERICA PHARMACEUTICAL INDUSTRY MARKET SHARE, BY TYPE (2021 V/S 2028) (%) 238
FIGURE 33 NORTH AMERICA CHEMICAL INDUSTRY MARKET SHARE, BY TYPE
(2021 V/S 2028 (%) 239
FIGURE 34 NORTH AMERICA OTHER INDUSTRIES MARKET SHARE, BY TYPE
(2021 V/S 2028) (%) 240
FIGURE 35 NORTH AMERICA TOXICOLOGY SERVICES MARKET SHARE, BY ENDPOINTS (2021 V/S 2028) (%) 241
FIGURE 36 NORTH AMERICA TOXICOLOGY SERVICES MARKET SHARE, BY COUNTRY (2021 V/S 2028) (%) 242
FIGURE 37 U.S. TOXICOLOGY SERVICES REVENUE, BY METHODS AND INDUSTRY
(2021 V/S 2028) ($MN) 246
FIGURE 38 U.S. TOXICOLOGY SERVICES MARKET REVENUE($MN) AND CAGR (%), BY ENDPOINTS (2021) 247
FIGURE 39 REST OF NORTH AMERICA TOXICOLOGY SERVICES MARKET REVENUE, BY METHODS AND INDUSTRY (2021 V/S 2028) ($MN) 250
FIGURE 40 REST OF NORTH AMERICA TOXICOLOGY SERVICES MARKET REVENUE ($MN) AND CAGR (%), BY ENDPOINTS (2021) 251
FIGURE 41 EUROPE TOXICOLOGY SERVICES MARKET SHARE, BY METHODS
(2021 V/S 2028) (%) 262
FIGURE 42 EUROPE IN VITRO TOXICOLOGY SERVICES MARKET SHARE, BY TYPE
(2021 V/S 2028) (%) 263
FIGURE 43 EUROPE TOXICOLOGY SERVICES MARKET SHARE, BY INDUSTRY
(2021 V/S 2028) (%) 264
FIGURE 44 EUROPE PHARMACEUTICAL INDUSTRY MARKET SHARE, BY TYPE
(2021 V/S 2028) (%) 265
FIGURE 45 EUROPE CHEMICAL INDUSTRY MARKET SHARE, BY TYPE
(2021 V/S 2028) (%) 266
FIGURE 46 EUROPE OTHER INDUSTRIES MARKET SHARE, BY TYPE (2021 V/S 2028) (%) 267
FIGURE 47 EUROPE TOXICOLOGY SERVICES MARKET SHARE, BY ENDPOINTS
(2021 V/S 2028) (%) 268
FIGURE 48 EUROPE TOXICOLOGY SERVICE SMARKET SHARE, BY COUNTRY
(2021 V/S 2028) (%) 270
FIGURE 49 GERMANY TOXICOLOGY SERVICES MARKET REVENUE, BY METHODS AND INDUSTRY (2021 V/S 2028) ($MN) 273
FIGURE 50 GERMANY TOXICOLOGY SERVICES MARKET REVENUE($MN) AND CAGR (%), BY END POINTS (2021) 274
FIGURE 51 FRANCE TOXICOLOGY SERVICES MARKET REVENUE, BY METHODS, AND INDUSTRY (2021 V/S 2028) ($MN) 276
FIGURE 52 FRANCE TOXICOLOGY SERVICES MARKET REVENUE ($MN) AND CAGR (%), BY END POINTS (2021) 277
FIGURE 53 U.K. TOXICOLOGY SERVICES MARKET REVENUE, BY METHODS AND INDUSTRY (2021 V/S 2028) ($MN) 279
FIGURE 54 U.K. TOXICOLOGY SERVICES MARKET REVENUE($MN) AND CAGR (%), BY END-POINTS (2021) 280
FIGURE 55 REST OF EUROPE TOXICOLOGY SERVICES MARKET REVENUE, BY METHODS AND INDUSTRY (2021 V/S 2028) ($MN) 282
FIGURE 56 REST OF EUROPE TOXICOLOGY SERVICES MARKET REVENUE ($MN) AND CAGR (%), BY ENDPOINTS (2021) 283
FIGURE 57 APAC TOXICOLOGY MARKET SHARE, BY METHODS (2021 V/S 2028) (%) 292
FIGURE 58 APAC IN VITRO TOXICOLOGY SERVICES MARKET SHARE, BY TYPE
(2021 V/S 2028) (%) 293
FIGURE 59 APAC TOXICOLOGY SERVICES MARKET SHARE, BY INDUSTRY
(2021 V/S 2028) (%) 294
FIGURE 60 APAC PHARMACEUTICAL INDUSTRY MARKET SHARE, BY TYPE
(2021 V/S 2028) (%) 295
FIGURE 61 APAC CHEMICAL INDUSTRY MARKET SHARE, BY TYPE (2021 V/S 2028) (%) 296
FIGURE 62 APAC OTHER INDUSTRIES MARKET SHARE, BY TYPE (2021 V/S 2028) (%) 297
FIGURE 63 APAC TOXICOLOGY SERVICES MARKET SHARE, BY ENDPOINTS
(2021 V/S 2028) (%) 298
FIGURE 64 ASIA-PACIFIC TOXICOLOGY SERVICES MARKET SHARE, BY COUNTRY
(2021 V/S 2028) (%) 300
FIGURE 65 JAPAN TOXICOLOGY SERVICESMARKET REVENUE, BY METHODS AND INDUSTRY (2021 V/S 2028) ($MN) 303
FIGURE 66 JAPAN TOXICOLOGY SERVICES MARKET REVENUE ($ MN) AND CAGR (%), BY ENDPOINTS (2021) 304
FIGURE 67 CHINA TOXICOLOGY SERVICES MARKET REVENUE, BY METHODS AND INDUSTRY (2021 V/S 2028) ($MN) 306
FIGURE 68 CHINA TOXICOLOGY SERVICES MARKET REVENUE ($ MN) AND CAGR (%), BY ENDPOINTS (2021) 307
FIGURE 69 INDIA TOXICOLOGY SERVICES MARKET REVENUE, BY METHODS AND INDUSTRY (2021 V/S 2028) ($MN) 311
FIGURE 70 INDIA TOXICOLOGY SERVICES MARKET REVENUE ($ MN) AND CAGR (%), BY END POINTS (2021) 312
FIGURE 71 REST OF APAC TOXICOLOGY SERVICES MARKET REVENUE, BY METHODS AND INDUSTRY (2021 V/S 2028) ($MN) 314
FIGURE 72 REST OF APAC TOXICOLOGY SERVICES MARKET REVENUE ($ MN) AND CAGR (%), BY END POINTS (2021) ($MN) 315
FIGURE 73 ROW TOXICOLOGY SERVICES MARKET SHARE, BY METHODS
(2021 V/S 2028) (%) 323
FIGURE 74 ROW IN VITRO TOXICOLOGY SERVICES MARKET SHARE, BY TYPE
(2021 V/S 2028) (%) 324
FIGURE 75 ROW TOXICOLOGY SERVICES MARKET SHARE, BY INDUSTRY
(2021 V/S 2028) (%) 325
FIGURE 76 ROW PHARMACEUTICAL INDUSTRY MARKET SHARE, BY TYPE
(2021 V/S 2028) (%) 326
FIGURE 77 ROW CHEMICAL INDUSTRY MARKET SHARE, BY TYPE (2021 V/S 2028) (%) 327
FIGURE 78 ROW OTHER INDUSTRIES MARKET SHARE, BY TYPE (2021 V/S 2028) (%) 328
FIGURE 79 ROW TOXICOLOGY SERVICES MARKET SHARE, BY ENDPOINTS
(2021 V/S 2028) (%) 329
FIGURE 80 ROW TOXICOLOGY SERVICES MARKET SHARE, BY COUNTRY (2021 V/S 2028) (%) 331
FIGURE 81 BRAZIL TOXICOLOGY SERVICES MARKET REVENUE, BY METHODS AND INDUSTRY (2021 VS 2028) ($MN) 333
FIGURE 82 BRAZIL TOXICOLOGY SERVICES MARKET REVENUE ($MN) AND CAGR (%), BY END POINTS (2021) 334
FIGURE 83 REST OF LATIN AMERICA TOXICOLOGY SERVICES MARKET REVENUE, BY METHODS AND INDUSTRY (2021 VS 2028) ($MN) 336
FIGURE 84 REST OF LATIN AMERICA TOXICOLOGY SERVICES MARKET REVENUE, BY ENDPOINTS ($MN) AND CAGR (%) (2021) 337
FIGURE 85 MIDDLE EAST & OTHERS TOXICOLOGY SERVICES MARKET REVENUE, BY METHODS AND INDUSTRY (2021 V/S 2028) ($MN) 340
FIGURE 86 MIDDLE EAST & OTHERS TOXICOLOGY SERVICES MARKET REVENUE ($ MN) AND CAGR (%), BY END POINTS (2021) 341
FIGURE 87 SWOT: CHARLES RIVER LABORATORIES 348
FIGURE 88 SWOT: CMIC HOLDINGS CO., LTD 353
FIGURE 89 SWOT: EVOTEC SE 361
FIGURE 90 SWOT: EUROFINS SCIENTIFIC S.E. 369
FIGURE 91 SWOT: INOTIV INC. 374
FIGURE 92 SWOT: ITR LABORATORIES CANADA INC. 377
FIGURE 93 SWOT: LABCORP CORPORATION OF AMERICA HOLDINGS 385
FIGURE 94 SWOT: NORTH AMERICAN SCIENCE ASSOCIATES, LLC 389
FIGURE 95 SWOT: PHARMARON BEIJING CO., LIMITED 396
FIGURE 96 SWOT: SGS SA 401
FIGURE 97 SWOT: WUXI APPTEC 410

渋谷データカウント

渋谷データカウントは、最も信頼性が高く最新の調査分析レポートを確実に提供する経験豊富な調査専門家のグローバルチームが提供する、さまざまな業界のさまざまな市場調査レポートを提供する再販代理店です。

Recommended reports

+